TA
Tamarack Advisers Portfolio holdings
AUM
$2.12M
This Quarter Return
-11.4%
1 Year Return
-56.28%
3 Year Return
-45.76%
5 Year Return
+44.93%
10 Year Return
–
AUM
$285M
AUM Growth
+$285M
(-46%)
Cap. Flow
-$190M
Cap. Flow
% of AUM
-66.57%
Top 10 Holdings %
Top 10 Hldgs %
76.51%
Holding
34
New
3
Increased
1
Reduced
13
Closed
10
Top Buys
| 1 |
Labcorp
LH
|
$13.5M |
| 2 |
ARIA
Ariad Pharmaceuticals Inc
ARIA
|
$10.2M |
| 3 |
Alkermes
ALKS
|
$6.33M |
| 4 |
DexCom
DXCM
|
$4.82M |
Top Sells
| 1 |
Integer Holdings
ITGR
|
$35.4M |
| 2 |
PDCO
Patterson Companies, Inc.
PDCO
|
$23.3M |
| 3 |
Quest Diagnostics
DGX
|
$20.4M |
| 4 |
Becton Dickinson
BDX
|
$19.3M |
| 5 |
Medtronic
MDT
|
$18.8M |
Sector Composition
| 1 | Healthcare | 79.79% |
| 2 | Technology | 7.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ELGX
1
DELISTED
Endologix Inc
ELGX
| $31.8M | 11.12% |
3,800,000
-675,000
| -15% | -$5.64M |
|
|
2
Quest Diagnostics
DGX
$20.3B
| $26.1M | 9.13% |
365,000
-285,000
| -44% | -$20.4M |
|
|
PDCO
3
DELISTED
Patterson Companies, Inc.
PDCO
| $25.6M | 8.96% |
550,000
-500,000
| -48% | -$23.3M |
|
|
NXTM
4
DELISTED
NxStage Medical Inc.
NXTM
| $25.5M | 8.92% |
1,700,000
-225,000
| -12% | -$3.37M |
|
|
MDRX
5
DELISTED
Veradigm Inc. Common Stock
MDRX
| $21.8M | 7.63% |
1,650,000
-200,000
| -11% | -$2.64M |
|
|
IMPR
6
DELISTED
IMPRIVATA, INC COM
IMPR
| $21.6M | 7.56% |
1,710,000
-36,000
| -2% | -$455K |
|
|
7
Medtronic
MDT
$119B
| $18.8M | 6.56% |
250,000
-250,000
| -50% | -$18.8M |
|
|
8
Alkermes
ALKS
$4.78B
| $16.6M | 5.8% |
485,000
+185,000
| +62% | +$6.33M |
|
|
SPNC
9
DELISTED
Spectranetics Corp
SPNC
| $16M | 5.59% |
1,100,000
-250,000
| -19% | -$3.63M |
|
|
LMNX
10
DELISTED
Luminex Corp
LMNX
| $14.6M | 5.09% |
750,000
-175,000
| -19% | -$3.4M |
|
11
Bio-Rad Laboratories Class A
BIO
$8.06B
| $13.7M | 4.79% |
100,000
-25,000
| -20% | -$3.42M |
|
|
12
Labcorp
LH
$23.1B
| $13.5M | 4.71% |
+115,000
| New | +$13.5M |
|
|
ARIA
13
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $10.2M | 3.58% |
+1,600,000
| New | +$10.2M |
|
14
AtriCure
ATRC
$1.84B
| $8.84M | 3.09% |
525,000
-175,000
| -25% | -$2.95M |
|
|
CORI
15
DELISTED
Corium International, Inc.
CORI
| $5.35M | 1.87% |
1,385,000
| – | – |
|
|
16
DexCom
DXCM
$29.5B
| $4.82M | 1.69% |
+71,000
| New | +$4.82M |
|
|
AMRN
17
Amarin Corp
AMRN
$311M
| $4.74M | 1.66% |
3,100,000
-2,400,000
| -44% | -$3.67M |
|
|
XENT
18
DELISTED
Intersect ENT, Inc
XENT
| $4.28M | 1.5% |
225,000
-24,296
| -10% | -$462K |
|
|
STRM
19
DELISTED
Streamline Health Solutions
STRM
| $1.61M | 0.56% |
1,138,000
| – | – |
|
20
AstraZeneca
AZN
$248B
| – | – |
-400,000
| Closed | -$13.6M |
|
|
21
Becton Dickinson
BDX
$55.3B
| – | – |
-125,000
| Closed | -$19.3M |
|
22
Glaukos
GKOS
$5.5B
| – | – |
-76,502
| Closed | -$1.89M |
|
|
23
Integer Holdings
ITGR
$3.78B
| – | – |
-675,000
| Closed | -$35.4M |
|
24
iShares S&P 100 ETF
OEF
$22B
| – | – |
0
| – | – |
|
|
SRGA
25
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| – | – |
-1,250,000
| Closed | -$4.96M |
|